KANSAS CITY, Mo.--(BUSINESS WIRE)--ViraCor Laboratories, a specialty molecular diagnostic reference laboratory, is the first national reference laboratory to offer the xTAG™ Respiratory Viral Panel (RVP) from Luminex Corporation (Nasdaq: LMNX), which yesterday received 510(K) clearance from the Food and Drug Administration (FDA). xTAG RVP is a novel molecular diagnostic product that detects 12 major respiratory viruses and subtypes simultaneously, from one patient sample. ViraCor was selected by Luminex to be an early adopter reference laboratory for the assay.
